Stay updated on IBI310 & Sintilimab in Advanced Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the IBI310 & Sintilimab in Advanced Cervical Cancer Clinical Trial page.

Latest updates to the IBI310 & Sintilimab in Advanced Cervical Cancer Clinical Trial page
- ChecktodayChange DetectedThe record history now includes Revision: v3.3.3. HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check36 days agoChange DetectedRemoved the government funding operating status notice banner from the page, a non-substantive change not affecting study data or user tasks; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check51 days agoChange DetectedA new version entry appears in the Record History, reflecting an update to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedMajor update: version bumped to v3.2.0 and a prominent government-operating-status notice added; previous v3.1.0 reference removed.SummaryDifference12%

- Check87 days agoChange DetectedVersion label updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.3%

Stay in the know with updates to IBI310 & Sintilimab in Advanced Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBI310 & Sintilimab in Advanced Cervical Cancer Clinical Trial page.